Osmotica Pharmaceuticals Q3 EPS $(2.15) Misses $(0.23) Estimate, Sales $65.461M Beat $52.21M Estimate

Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(2.15) per share which missed the analyst consensus estimate of $(0.23) by 834.78 percent. This is a 2587.5 percent decrease over losses of $(0.08) per

Benzinga · 11/14/2019 21:31

Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(2.15) per share which missed the analyst consensus estimate of $(0.23) by 834.78 percent. This is a 2587.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $65.461 million which beat the analyst consensus estimate of $52.21 million by 25.38 percent. This is a 1.33 percent decrease over sales of $66.345 million the same period last year.